Stay updated on NIMBLe Study: Clinical Trial_hyperMutated Cancers
Sign up to get notified when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.

Latest updates to the NIMBLe Study: Clinical Trial_hyperMutated Cancers page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section added listing New York, Alberta, British Columbia, and Ontario; HHS Vulnerability Disclosure removed; location headings consolidated under a single Locations section (Revision: v3.3.3).SummaryDifference0.5%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision was updated from v3.3.1 to v3.3.2, with no substantive changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page now displays revision v3.3.1, replacing the previous v3.2.0; no changes to the study details or related content are evident.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the funding-status banner about government operating status from the study page, which does not affect trial details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedNo additions or deletions were detected on the page; the study record content and layout appear unchanged.SummaryDifference0.4%

- Check91 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to NIMBLe Study: Clinical Trial_hyperMutated Cancers
Enter your email address, and we'll notify you when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.